January / February 2025
Features
Home-OCT guided treatment for neovascular age-related macular degeneration
This technology may help ease the treatment burden.
The year of biosimilars, and list goes well beyond 100
Five aflibercept biosimilars and only one other therapy gained FDA approval in 2024, but 20 new candidates join the list.
Departments
Editor's Page
Imaging Forum
Floaters and discomfort in an immunocompetent patient
How to follow the diagnostic clues and clinch the diagnosis.
Social Media Specialist
Deciphering the latest FDA misinformation guidelines
We must try to strike a balance between overregulation and no regulation at all.
Surgical Pearl Video
Surgical management of diffuse choroidal hemangioma
How to use external drainage of subretinal fluid in exudative retinal detachment secondary to diffuse choroidal hemangioma.
Current Issue
Additional Publications
Learn More about Stargardt Disease
Earlier Treatment Can Matter for Macular Edema Following Retinal Vein Occlusion
Treating Chronic Inflammation Associated With Uveitis Affecting the Posterior Segment in a Retina Setting with YUTIQ
GA: Recognizing the Burden
Treatment of Proliferative Diabetic Retinopathy
